Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Sci-Tech News Today.
Press releases published on August 26, 2025

Louis Bélanger-Martin Taps Australian Market for High-Impact Aviation Tech Pilots
Photo Courtesy of: Louis Bélanger-Martin SYDNEY, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Louis Bélanger-Martin, a longtime figure in aviation technology, is focusing his next phase of development on Australia. The Canadian entrepreneur, known for co-founding DTI …

Sana Biotechnology to Present at September 2025 Investor Conferences
SEATTLE, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sana Biotechnology, Inc. (NASDAQ: SANA), a company focused on changing the possible for patients through engineered cells, today announced that it will webcast its presentations at four investor conferences in …

Seer to Participate in the Morgan Stanley 23rd Annual Global Healthcare Conference
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Seer, Inc. (Nasdaq: SEER), the pioneer and trusted partner for deep, unbiased proteomic insights, today announced that the company will be participating in the upcoming Morgan Stanley 23rd Annual …

Lesaka to Host Webcast and Conference Call to Review Fourth Quarter and Year-End 2025 Results on September 11, 2025
JOHANNESBURG, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Lesaka Technologies, Inc. (NASDAQ:LSAK, JSE: LSK) ("Lesaka") now intends to release fourth quarter and year-end 2025 results after the U.S. market close on September 10, 2025. Lesaka management will host a …

Immuneering Announces Closing of $25 Million Private Placement
CAMBRIDGE, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Immuneering Corporation (Nasdaq: IMRX), a clinical-stage oncology company focused on keeping cancer patients alive, today announced the closing of its previously announced private placement. The private …

Pulmonx to Participate in September Investor Conferences
REDWOOD CITY, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (“Pulmonx” or the "Company"), a global leader in minimally invasive treatments for lung disease, today announced that management will present at the following …

iMDx to Participate in NYC Investment Conferences September 8 - 11
NASHVILLE, Tenn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Insight Molecular Diagnostics Inc., or iMDx, (Nasdaq: IMDX), today announced participation in investor conferences hosted by both H.C. Wainwright and Lake Street Capital Markets. Information for each can …

3D Systems Receives $7.65 Million Contract Award from U.S. Air Force for Advanced Metal Printing System
Two-year contract award for Large-format Metal 3D Printer Advanced Technology Demonstrator Supports development of large-scale industrial metal AM print capabilities for high-speed flight applications Award is an extension of an existing program to …

IRADIMED CORPORATION to Participate in the 2025 Wells Fargo Healthcare Conference
ORLANDO, Fla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), a leader in innovative medical devices for Magnetic Resonance Imaging (“MRI”) compatible patient monitoring and infusion systems, today announced that it will participate …

Zentalis Pharmaceuticals Appoints James B. Bucher, JD, as Chief Legal Officer and Corporate Secretary
SAN DIEGO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Zentalis® Pharmaceuticals, Inc. (Nasdaq: ZNTL), a clinical-stage biopharmaceutical company developing a potentially first-in-class and best-in-class WEE1 inhibitor for patients with ovarian cancer and other …

nCino Reports Second Quarter Fiscal Year 2026 Financial Results
Total Revenues of $148.8M, up 12% year-over-year Subscription Revenues of $130.8M, up 15% year-over-year WILMINGTON, N.C., Aug. 26, 2025 (GLOBE NEWSWIRE) -- nCino, Inc. (NASDAQ: NCNO), the leading provider of intelligent, best-in-class banking solutions, …

NovaBay Pharmaceuticals Announces One-Time Special Cash Dividend of $0.80 Per Share
EMERYVILLE, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- NovaBay® Pharmaceuticals, Inc. (NYSE American: NBY) (“NovaBay” or the “Company”) announces its Board of Directors and the Special Transaction Committee of the Board of Directors has declared a one-time …

Sight Sciences to Present at the Upcoming Morgan Stanley Global Healthcare Conference
MENLO PARK, Calif., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Sight Sciences, Inc. (Nasdaq: SGHT) (Sight Sciences or the Company) an eyecare technology company focused on developing and commercializing innovative, interventional technologies intended to transform …

Matrix Service Company Sets Date for Release of Fiscal Year 2025 Fourth Quarter and Full-Year Results and Conference Call
TULSA, Okla., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Matrix Service Company (Nasdaq: MTRX), a leading provider of engineering and construction services to the energy and industrial markets, announced today that it will release fourth quarter and full-year …

CompoSecure Highlights its Arculus Onchain Tap-to-Pay Capability and Showcases Innovation at Stablecoin Conference LATAM 2025
SOMERSET, N.J., Aug. 26, 2025 (GLOBE NEWSWIRE) -- CompoSecure, Inc. (Nasdaq: CMPO), a leader in metal payment cards, security, and authentication solutions, today announced it will showcase its Arculus direct onchain tap-to-pay capability and that its Head …

Cognition Therapeutics Regains Compliance with Nasdaq Minimum Bid Price Requirement
PURCHASE, N.Y., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc., (the “Company” or “Cognition”) (NASDAQ: CGTX), a clinical-stage company developing drugs that treat neurodegenerative disorders, was notified by The Nasdaq Listing …

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences
NEWTON, Mass., Aug. 26, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing novel therapeutics that target toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s disease …

Akka and Deloitte Canada Collaborate to Deliver Agentic AI at Scale
SAN FRANCISCO, Aug. 26, 2025 (GLOBE NEWSWIRE) -- Akka, formerly known as Lightbend and the inventors of the Akka Agentic Platform, today announced a collaboration with Deloitte Canada, in which both companies have agreed to jointly tackle the issue of …

BioXcel Therapeutics To Announce Topline Results from SERENITY At-Home Pivotal Phase 3 Safety Trial for Acute Treatment of Agitation Associated with Bipolar Disorders or Schizophrenia on August 27, 2025
NEW HAVEN, Conn., Aug. 26, 2025 (GLOBE NEWSWIRE) -- BioXcel Therapeutics, Inc. (Nasdaq: BTAI), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that it will host an investor …

Robotimize Unveils Comprehensive Rehabilitation Technology Showcase at AOCPRM 2025
Robotimize showcases 8 integrated rehab systems at AOCPRM 2025, uniting robotics and neurotech to scale evidence-based outcomes across Asia–Pacific. PENANG, MALAYSIA, August 26, 2025 /EINPresswire.com/ -- Robotimize Group, a global leader in intelligent …